Vranes J et al. |
Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated escherichia coli. |
1996 |
J Chemother |
pmid:8873829
|
Laing RB et al. |
Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. |
1996 |
Int J STD AIDS |
pmid:8876356
|
Tansey MJ and Moe JB |
Severe neutropenia and prophylactic doses of rifabutin. |
1996 |
Lancet |
pmid:8950911
|
Sefton AM et al. |
Azithromycin in the treatment of periodontal disease. Effect on microbial flora. |
1996 |
J. Clin. Periodontol. |
pmid:8951627
|
Griffith DE et al. |
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease. |
1996 |
Clin. Infect. Dis. |
pmid:8953085
|
Brihmer C et al. |
Efficacy and safety of azithromycin versus lymecyline in the treatment of genital chlamydial infections in women. |
1996 |
Scand. J. Infect. Dis. |
pmid:8953672
|
|
Prophylactic antibiotic receives speedy FDA approval to reduce MAC disease in advanced HIV. |
1996 |
AIDS Patient Care STDS |
pmid:11361569
|
Van Bambeke F et al. |
Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. |
1996 |
Eur. J. Pharmacol. |
pmid:8957238
|
|
Azithromycin and OIs. |
1996 |
AIDS Patient Care STDS |
pmid:11361699
|
Montenez JP et al. |
Interaction of the macrolide azithromycin with phospholipids. II. Biophysical and computer-aided conformational studies. |
1996 |
Eur. J. Pharmacol. |
pmid:8957239
|
Prescott LM |
Macrolides, azalides, and streptogrammins. |
1996 |
J Int Assoc Physicians AIDS Care |
pmid:11363516
|
Currier J |
Progress report: prophylaxis and therapy for MAC. |
1996 |
AIDS Clin Care |
pmid:11363599
|
|
Old drug approved for MAC prevention. |
1996 |
AIDS Alert |
pmid:11363659
|
Torres G |
MAC prophylaxis revisited. |
1996 |
GMHC Treat Issues |
pmid:11363706
|
Gris P |
Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818850
|
Zachariah J |
A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818851
|
Laurent K |
Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818852
|
Montero L |
A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818853
|
Nahata M |
Drug interactions with azithromycin and the macrolides: an overview. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818854
|
Treadway G and Pontani D |
Paediatric safety of azithromycin: worldwide experience. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818855
|
Carbon C et al. |
Economic analysis of antibiotic regimens used in the treatment pharyngitis: a prospective comparison of azithromycin versus roxithromycin. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818856
|
Haruta T and Kobayashi Y |
[Therapeutic efficacy of azithromycin in pediatrics]. |
1996 |
Jpn J Antibiot |
pmid:8986555
|
Kuroda Y and Ito M |
[Therapy with azithromycin in pediatric infections]. |
1996 |
Jpn J Antibiot |
pmid:8986556
|
Okamoto T and Sekiguchi T |
[Clinical studies on azithromycin in pediatrics]. |
1996 |
Jpn J Antibiot |
pmid:8986557
|
Toyonaga Y et al. |
[Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients]. |
1996 |
Jpn J Antibiot |
pmid:8988410
|
Okumura A and Kuno K |
[Pharmacokinetic and clinical evaluation of azithromycin in pediatrics]. |
1996 |
Jpn J Antibiot |
pmid:8988411
|
Kobayashi Y et al. |
[Clinical study of a macrolide antibiotic, azithromycin, in pediatric patients]. |
1996 |
Jpn J Antibiot |
pmid:8988412
|
Furukawa S and Okada T |
[A clinical evaluation of azithromycin in the treatment of pediatric infection]. |
1996 |
Jpn J Antibiot |
pmid:8988413
|
Okada T et al. |
[Pharmacokinetic and clinical evaluations of azithromycin in the pediatric field]. |
1996 |
Jpn J Antibiot |
pmid:8988414
|
Ishida Y et al. |
[Pharmacokinetic and clinical evaluation of azithromycin in pediatric infections]. |
1996 |
Jpn J Antibiot |
pmid:8988415
|
Ohtsuka Y et al. |
[Pharmacokinetic and clinical studies on azithromycin in children]. |
1996 |
Jpn J Antibiot |
pmid:8988416
|
Nickel P and Näher H |
Nongonococcal urethritis. |
1996 |
Curr. Probl. Dermatol. |
pmid:8743259
|
Johnson RB |
Azithromycin. |
1996 |
Curr. Probl. Dermatol. |
pmid:8743269
|
Caselli M et al. |
A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication. |
1996 |
J. Antimicrob. Chemother. |
pmid:8722557
|
Falagas ME and Klempner MS |
Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. |
1996 |
Clin. Infect. Dis. |
pmid:8722936
|
Murphy GS et al. |
Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. |
1996 |
Clin. Infect. Dis. |
pmid:8722958
|
Scorneaux B et al. |
Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8723471
|
Havlir DV et al. |
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. |
1996 |
N. Engl. J. Med. |
pmid:8676932
|
Tursi A et al. |
The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection. |
1996 |
Am. J. Gastroenterol. |
pmid:8677967
|
Thorpe EM et al. |
Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises. |
1996 |
Genitourin Med |
pmid:8698374
|
Wilton LV et al. |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. |
1996 |
Br J Clin Pharmacol |
pmid:8730972
|
Thylefors B |
Trachoma--new opportunities to tackle an old problem. |
1996 |
Br J Ophthalmol |
pmid:9059262
|
Cammarota G et al. |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971300
|
Pilotto A et al. |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971305
|
Evans LA et al. |
Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell model. |
1996 |
Pharm. Res. |
pmid:8899856
|
O'Doherty B |
Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group. |
1996 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8922571
|
Griffith DE et al. |
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. |
1996 |
Clin. Infect. Dis. |
pmid:8922790
|
Chulig I |
[Pharmacokinetic profile of azithromycin. Role in the treatment of genital Chlamydia infections]. |
1996 |
Antibiot. Khimioter. |
pmid:8929112
|
Kuznetsova SM |
["Sumamed in the treatment of urogenital infections"]. |
1996 |
Antibiot. Khimioter. |
pmid:8929115
|
Skripkin IuK et al. |
[The problem of diagnosis and treatment of urogenital chlamydiosis in Russia]. |
1996 |
Antibiot. Khimioter. |
pmid:8929120
|